To investigate whether CD36 mediates the CB2R-induced phagocytic activity of TAMs in glioma, we sorted CD11b-positive TAMs using flow cytometry and examined the expression of CD36 in each group. This evidence concerns the gene CD36 and central nervous system cancer.